StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Novavax (NVAX) PT Raised to $38 at Ladenburg Thalmann
May 12, 2020 8:19 AM
Ladenburg Thalmann analyst Michael Higgins raised the price target on Novavax (NASDAQ: NVAX) to $38.00 (from $28.00) while maintaining a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Next Articles
Novavax (NVAX) PT Raised to $50 at H.C. Wainwright as Large Investment Signals Company is Underappreciated
May 12, 2020 7:52 AM
Novavax (NVAX) PT Raised to $38.50 at Oppenheimer
May 12, 2020 7:38 AM
Novavax (NVAX) Tops Q1 EPS by 20c, Revenues Beat
May 11, 2020 5:04 PM
Form 10-Q NOVAVAX INC For: Mar 31
May 11, 2020 4:34 PM
Epidemic response group to invest up to $384 mln in Novavax's COVID-19 vaccine
May 11, 2020 4:07 PM
Novavax (NVAX) Announces $388M Funding from CEPI for COVID-19 Vaccine
May 11, 2020 4:06 PM
Novavax to Receive up to $388 Million Funding from CEPI for COVID-19 Vaccine Development and Manufacturing
May 11, 2020 4:03 PM
Novavax to Receive up to $388 Million Funding from CEPI for COVID-19 Vaccine Development and Manufacturing
May 11, 2020 4:02 PM
